Derivatives of isoquinolinone and dihydrolisoquinolinone, and related compounds, and their use as pharmaceuticals in the treatment of a disease by inhibition of the enzyme poly(ADP-ribose)polymerase (“PARP”) are disclosed.
本发明公开了
异喹啉酮和二氢
异喹啉酮及其衍
生物的衍
生物,以及它们在通过抑制酶聚(
ADP-
核糖)聚合酶(“PARP”)治疗疾病中作为药物的应用。